To determine whether the pro-survival effect of co-culture and BCR stimulation might be abrogated by TAK-659, we treated co-cultured and anti-IgM stimulated CLL cells with increasing doses of TAK-659. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.